Sales rise 20.71% to Rs 89.65 crore
Net profit of Lincoln Pharmaceuticals rose 27.83% to Rs 11.30 crore in the quarter ended September 2017 as against Rs 8.84 crore during the previous quarter ended September 2016. Sales rose 20.71% to Rs 89.65 crore in the quarter ended September 2017 as against Rs 74.27 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales89.6574.27 21 OPM %17.2115.56 -PBDT16.9313.19 28 PBT15.1211.91 27 NP11.308.84 28Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)